SCHEMBL7519641

SCHEMBL7519641

O=C(O)c1ccc(-c2ccc3cc(OCc4ccc(F)cc4)c(C45CC6CC(CC(C6)C4)C5)cc3c2)cc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
THRB P10828 1/20 0.50
RECQL P46063 1/20 0.50
NR2E1 Q9Y466 1/20 0.50
RARB P10826 7/20 0.46
RARG P13631 7/20 0.46
RARA P10276 4/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
NR1I2 O75469 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7517611 0.92 MEN1 (0.53) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7929991 0.91 KMT2A (0.44) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7929545 0.83 RARB (0.47) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8438827 0.83 MEN1 (0.66) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7515780 0.81 RARB (0.51) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8457461 0.80 RARB (0.48) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL29462745 0.80 IKBKB (0.52) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL2919467 0.80 IKBKB (0.52) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7518648 0.79 MEN1 (0.64) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL8657238 0.79 MEN1 (0.76) MEN1KMT2ATHRBRECQLNR2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854711-B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR GALDERMA RECH DERMATOLOGIQUE (FR) 2002-01-23 EP claimed
US-6063797-A γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor C.I.R.D. GALDERMA (FR) 2000-05-16 US claimed
EP-0658553-B1 Polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof CIRD GALDERMA (FR) 1998-11-04 EP claimed
US-6225328-B1 FOR THERAPY OF DISORDERS OR AILMENTS RELATED TO AN OVERREGULATION OF RETINOIC ACID RECEPTORS AND/OR TO HYPERVIAMINOSIS A CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-05-01 US disclosed
US-6063797-A γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor C.I.R.D. GALDERMA (FR) 2000-05-16 US disclosed
EP-0658553-B1 Polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof CIRD GALDERMA (FR) 1998-11-04 EP disclosed
EP-0740937-A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1996-11-06 EP disclosed
EP-0658553-A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-06-21 EP disclosed